Solid lipid nanoparticles of irbesartan: preparation, characterization, optimization and pharmacokinetic studies

AUTOR(ES)

Soma, Deepthi, Attari, Zenab, Reddy, Meka Sreenivasa, Damodaram, Atmakuri, Koteshwara, Kunnatur Balasundara Gupta

FONTE

Braz. J. Pharm. Sci.

DATA DE PUBLICAÇÃO

20/04/2017

RESUMO

ABSTRACT Irbesartan is an antihypertensive with limited bioavailability and solid lipid nanoparticles (SLN) is one of the approaches to improve bioavailability. Solid lipid nanoparticles were prepared using glyceryl monostearate by solvent emulsification method followed by probe sonication. Irbesartan loaded SLNs were characterized and optimized by parameters like particle size, zeta potential, surface morphology entrapment efficiency and in vitro release. The optimized formulation was then further evaluated for the pharmacokinetic studies in Wistar rats. Irbesartan-loaded SLN of particle size 523.7 nm and 73.8% entrapment efficiency showed good bioavailability in Wistar rats and also showed optimum stability in the studies. The SLN prepared using glyceryl monostearate by solvent emulsification method leads to improve bioavailability of the drug.

Documentos Relacionados

• Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles
• Preparation, characterization and evaluation of moisturizing and UV protecting effects of topical solid lipid nanoparticles
• Microbial mediated preparation, characterization and optimization of gold nanoparticles
• Preparation, characterization, and antiproliferative activities of biotin-decorated docetaxel-loaded bovine serum albumin nanoparticles
• Preparation, characterization, and in vivo evaluation of salmon calcitonin microspheres